Literature DB >> 19135342

Methotrexate-incorporated polymeric nanoparticles of methoxy poly(ethylene glycol)-grafted chitosan.

Dong-Hyuk Seo1, Young-Il Jeong, Don-Gon Kim, Min-Ja Jang, Mi-Kyeong Jang, Jae-Woon Nah.   

Abstract

We prepared methotrexate (MTX)-encapsulated polymeric nanoparticles using methoxy poly(ethylene glycol) (MPEG)-grafted chitosan (ChitoPEG) copolymer. MTX-encapsulated polymeric nanoparticles of ChitoPEG copolymer has around 50-300nm in particle size and showed spherical shape when observed by transmission electron microscope (TEM). In (1)H nuclear magnetic resonance (NMR) study, the specific peaks of MTX and chitosan as a drug carrying inner-core disappeared at D(2)O and only the specific peak of MPEG was observed, while specific peaks of MPEG, MTX, and chitosan appeared in DCl/D(2)O mixtures. These results indicated that MTX was complexed with chitosan and then core-shell type nanoparticles had formed in aqueous environment, i.e., MTX/chitosan complexes composed of inner-core and MPEG composed of outer-shell of the nanoparticles. Loading efficiency of MTX in the polymeric nanoparticles was 94% (w/w) of ChitoPEG-1, 91.1% (w/w) of ChitoPEG-2, 90.1% (w/w) of ChitoPEG-3 and 65.2% (w/w) of ChitoPEG-4, expectively. The higher the drug feeding ratio, the higher the drug content and the lower the loading efficiency. The higher the MPEG graft ratio in the copolymer, the lower the drug content and loading efficiency. Drug contents evaluated by (1)H NMR were the same as found by UV spectrophotometer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19135342     DOI: 10.1016/j.colsurfb.2008.10.020

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  9 in total

1.  Sustained release of methotrexate through liquid-crystalline folate nanoparticles.

Authors:  Rahul Misra; Sanat Mohanty
Journal:  J Mater Sci Mater Med       Date:  2014-06-22       Impact factor: 3.896

2.  Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.

Authors:  Zulfequar Ahamad Khan; Rahul Tripathi; Brahmeshwar Mishra
Journal:  AAPS PharmSciTech       Date:  2011-10-04       Impact factor: 3.246

3.  Novel formulation of a methotrexate derivative with a lipid nanoemulsion.

Authors:  Juliana A Moura; Claudete J Valduga; Elaine R Tavares; Iara F Kretzer; Durvanei A Maria; Raul C Maranhão
Journal:  Int J Nanomedicine       Date:  2011-10-12

4.  A Smart Drug Delivery System Based on Biodegradable Chitosan/Poly(allylamine hydrochloride) Blend Films.

Authors:  Muhammad Sohail Sarwar; Qingrong Huang; Abdul Ghaffar; Muhmmad Amin Abid; Muhammad Sohail Zafar; Zohaib Khurshid; Muhammad Latif
Journal:  Pharmaceutics       Date:  2020-02-04       Impact factor: 6.321

5.  pH Responsive Abelmoschus esculentus Mucilage and Administration of Methotrexate: In-Vitro Antitumor and In-Vivo Toxicity Evaluation.

Authors:  Sobia Noreen; Sara Hasan; Shazia Akram Ghumman; Syed Nasir Abbas Bukhari; Bushra Ijaz; Huma Hameed; Huma Iqbal; Afeefa Aslam; Mervat Abdelaziz Mohamed Elsherif; Shazia Noureen; Hasan Ejaz
Journal:  Int J Mol Sci       Date:  2022-03-01       Impact factor: 5.923

6.  5-aminolevulinic acid-incorporated nanoparticles of methoxy poly(ethylene glycol)-chitosan copolymer for photodynamic therapy.

Authors:  Chung-Wook Chung; Kyu-Don Chung; Young-Il Jeong; Dae Hwan Kang
Journal:  Int J Nanomedicine       Date:  2013-02-25

Review 7.  Particles from preformed polymers as carriers for drug delivery.

Authors:  K Miladi; D Ibraheem; M Iqbal; S Sfar; H Fessi; A Elaissari
Journal:  EXCLI J       Date:  2014-02-03       Impact factor: 4.068

8.  Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles.

Authors:  Zaina Ait Bachir; YuKun Huang; MuYe He; Lei Huang; XinYu Hou; RongJun Chen; Feng Gao
Journal:  Int J Nanomedicine       Date:  2018-09-24

9.  Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line.

Authors:  Mohammad Reza Molaahmadi; Jaleh Varshosaz; Somayeh Taymouri; Vajihe Akbari
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.